Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Xtant Medical Holdings (XTNT) Invested Capital (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Invested Capital for 16 consecutive years, with $61.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Invested Capital rose 27.26% to $61.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was $61.7 million, a 27.26% increase, with the full-year FY2024 number at $55.1 million, down 1.59% from a year prior.
  • Invested Capital was $61.7 million for Q3 2025 at Xtant Medical Holdings, up from $60.5 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $61.7 million in Q3 2025 to a low of $31.9 million in Q2 2022.
  • A 5-year average of $46.3 million and a median of $47.4 million in 2023 define the central range for Invested Capital.
  • Biggest YoY gain for Invested Capital was 181.01% in 2021; the steepest drop was 24.71% in 2021.
  • Xtant Medical Holdings' Invested Capital stood at $34.5 million in 2021, then increased by 27.11% to $43.9 million in 2022, then grew by 27.62% to $56.0 million in 2023, then dropped by 1.59% to $55.1 million in 2024, then increased by 12.0% to $61.7 million in 2025.
  • Per Business Quant, the three most recent readings for XTNT's Invested Capital are $61.7 million (Q3 2025), $60.5 million (Q2 2025), and $55.1 million (Q1 2025).